These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
281 related articles for article (PubMed ID: 27602581)
1. Computational identification of microRNAs associated to both epithelial to mesenchymal transition and NGAL/MMP-9 pathways in bladder cancer. Falzone L; Candido S; Salemi R; Basile MS; Scalisi A; McCubrey JA; Torino F; Signorelli SS; Montella M; Libra M Oncotarget; 2016 Nov; 7(45):72758-72766. PubMed ID: 27602581 [TBL] [Abstract][Full Text] [Related]
2. Investigation of key miRNAs and target genes in bladder cancer using miRNA profiling and bioinformatic tools. Canturk KM; Ozdemir M; Can C; Öner S; Emre R; Aslan H; Cilingir O; Ciftci E; Celayir FM; Aldemir O; Özen M; Artan S Mol Biol Rep; 2014 Dec; 41(12):8127-35. PubMed ID: 25189652 [TBL] [Abstract][Full Text] [Related]
3. MiRNA-141 and miRNA-200b are closely related to invasive ability and considered as decision-making biomarkers for the extent of PLND during cystectomy. Liu W; Qi L; Lv H; Zu X; Chen M; Wang J; Liu L; Zeng F; Li Y BMC Cancer; 2015 Mar; 15():92. PubMed ID: 25884322 [TBL] [Abstract][Full Text] [Related]
4. High-throughput mRNA and miRNA profiling of epithelial-mesenchymal transition in MDCK cells. Shukla P; Vogl C; Wallner B; Rigler D; Müller M; Macho-Maschler S BMC Genomics; 2015 Nov; 16():944. PubMed ID: 26572553 [TBL] [Abstract][Full Text] [Related]
5. Connecting the dots between different networks: miRNAs associated with bladder cancer risk and progression. Braicu C; Buiga R; Cojocneanu R; Buse M; Raduly L; Pop LA; Chira S; Budisan L; Jurj A; Ciocan C; Magdo L; Irimie A; Dobrota F; Petrut B; Berindan-Neagoe I J Exp Clin Cancer Res; 2019 Oct; 38(1):433. PubMed ID: 31665050 [TBL] [Abstract][Full Text] [Related]
6. Identification and validation of reference genes for the detection of serum microRNAs by reverse transcription-quantitative polymerase chain reaction in patients with bladder cancer. Wang L; Liu Y; Du L; Li J; Jiang X; Zheng G; Qu A; Wang H; Wang L; Zhang X; Liu H; Pan H; Yang Y; Wang C Mol Med Rep; 2015 Jul; 12(1):615-22. PubMed ID: 25738263 [TBL] [Abstract][Full Text] [Related]
7. A Polycomb-mir200 loop regulates clinical outcome in bladder cancer. Martínez-Fernández M; Dueñas M; Feber A; Segovia C; García-Escudero R; Rubio C; López-Calderón FF; Díaz-García C; Villacampa F; Duarte J; Gómez-Rodriguez MJ; Castellano D; Rodriguez-Peralto JL; de la Rosa F; Beck S; Paramio JM Oncotarget; 2015 Dec; 6(39):42258-75. PubMed ID: 26517683 [TBL] [Abstract][Full Text] [Related]
8. Dual regulation by microRNA-200b-3p and microRNA-200b-5p in the inhibition of epithelial-to-mesenchymal transition in triple-negative breast cancer. Rhodes LV; Martin EC; Segar HC; Miller DF; Buechlein A; Rusch DB; Nephew KP; Burow ME; Collins-Burow BM Oncotarget; 2015 Jun; 6(18):16638-52. PubMed ID: 26062653 [TBL] [Abstract][Full Text] [Related]
9. PRMT5 Circular RNA Promotes Metastasis of Urothelial Carcinoma of the Bladder through Sponging miR-30c to Induce Epithelial-Mesenchymal Transition. Chen X; Chen RX; Wei WS; Li YH; Feng ZH; Tan L; Chen JW; Yuan GJ; Chen SL; Guo SJ; Xiao KH; Liu ZW; Luo JH; Zhou FJ; Xie D Clin Cancer Res; 2018 Dec; 24(24):6319-6330. PubMed ID: 30305293 [TBL] [Abstract][Full Text] [Related]
10. Identification and bioinformatics analysis of miRNAs associated with human muscle invasive bladder cancer. Chen L; Yuan L; Wang G; Cao R; Peng J; Shu B; Qian G; Wang X; Xiao Y Mol Med Rep; 2017 Dec; 16(6):8709-8720. PubMed ID: 28990088 [TBL] [Abstract][Full Text] [Related]
11. miR-451 inhibits invasion and proliferation of bladder cancer by regulating EMT. Zeng T; Peng L; Chao C; Fu B; Wang G; Wang Y; Zhu X Int J Clin Exp Pathol; 2014; 7(11):7653-62. PubMed ID: 25550801 [TBL] [Abstract][Full Text] [Related]
12. Double-negative feedback loop between long non-coding RNA TUG1 and miR-145 promotes epithelial to mesenchymal transition and radioresistance in human bladder cancer cells. Tan J; Qiu K; Li M; Liang Y FEBS Lett; 2015 Oct; 589(20 Pt B):3175-81. PubMed ID: 26318860 [TBL] [Abstract][Full Text] [Related]
13. Identification of circulating miRNAs as novel prognostic biomarkers for bladder cancer. Lin GB; Zhang CM; Chen XY; Wang JW; Chen S; Tang SY; Yu TQ Math Biosci Eng; 2019 Nov; 17(1):834-844. PubMed ID: 31731380 [TBL] [Abstract][Full Text] [Related]
14. Diagnostic value of neutrophil gelatinase-associated lipocalin/matrix metalloproteinase-9 pathway in transitional cell carcinoma of the bladder. Candido S; Di Maso M; Serraino D; McCubrey JA; Bortolus R; Zanin M; Battiston M; Salemi R; Libra M; Polesel J Tumour Biol; 2016 Jul; 37(7):9855-63. PubMed ID: 26810191 [TBL] [Abstract][Full Text] [Related]
15. Screening biomarkers of bladder cancer using combined miRNA and mRNA microarray analysis. Jin N; Jin X; Gu X; Na W; Zhang M; Zhao R Mol Med Rep; 2015 Aug; 12(2):3170-6. PubMed ID: 25955758 [TBL] [Abstract][Full Text] [Related]
16. Role of microRNA/Epithelial-to-Mesenchymal Transition Axis in the Metastasis of Bladder Cancer. Ashrafizadeh M; Hushmandi K; Hashemi M; Akbari ME; Kubatka P; Raei M; Koklesova L; Shahinozzaman M; Mohammadinejad R; Najafi M; Sethi G; Kumar AP; Zarrabi A Biomolecules; 2020 Aug; 10(8):. PubMed ID: 32784711 [TBL] [Abstract][Full Text] [Related]
17. c-Met and CREB1 are involved in miR-433-mediated inhibition of the epithelial-mesenchymal transition in bladder cancer by regulating Akt/GSK-3β/Snail signaling. Xu X; Zhu Y; Liang Z; Li S; Xu X; Wang X; Wu J; Hu Z; Meng S; Liu B; Qin J; Xie L; Zheng X Cell Death Dis; 2016 Feb; 7(2):e2088. PubMed ID: 26844702 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA-Mediated Post-Transcriptional Regulation of Epithelial to Mesenchymal Transition in Cancer. Behbahani GD; Ghahhari NM; Javidi MA; Molan AF; Feizi N; Babashah S Pathol Oncol Res; 2017 Jan; 23(1):1-12. PubMed ID: 27590333 [TBL] [Abstract][Full Text] [Related]
19. Gene expression profiling of microRNAs associated with UCA1 in bladder cancer cells. Xie X; Pan J; Wei L; Wu S; Hou H; Li X; Chen W Int J Oncol; 2016 Apr; 48(4):1617-27. PubMed ID: 26820254 [TBL] [Abstract][Full Text] [Related]
20. CAV-1 contributes to bladder cancer progression by inducing epithelial-to-mesenchymal transition. Liang W; Hao Z; Han JL; Zhu DJ; Jin ZF; Xie WL Urol Oncol; 2014 Aug; 32(6):855-63. PubMed ID: 24968949 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]